Ionis Pharmaceuticals IONS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $173.38M-34.4% | $372.26M+53.8% | $338.34M+1.1% | $297.3M+1.1% | $264.19M-24.3% | ||
| $1.12B-9.4% | $1.58B+12.5% | $1.28B-14.2% | $1.33B-0.8% | $1.23B-5.4% | ||
| $5.56M-51.7% | $10.05M-19.7% | $10.47M-63.2% | $8.48M-70.5% | $11.5M-62.0% | ||
| $2.94B+21.4% | $2.99B+14.1% | $2.52B-7.2% | $2.58B+10.6% | $2.42B+0.1% | ||
| $142.4M+38.4% | $123.05M+30.6% | $106.12M+28.6% | $111.95M+47.5% | $102.93M+41.4% | ||
| —— | —— | —— | —— | —— | ||
| $3.45B+22.6% | $3.52B+17.3% | $3.03B-1.6% | $2.99B+10.9% | $2.81B+1.8% | ||
| $26.03M+49.1% | $28.08M-34.6% | $14.33M+58.3% | $22.8M+147% | $17.46M+33.4% | ||
| $69.2M-14.7% | $73.76M-6.6% | $76.99M+1.3% | $75.91M-19.3% | $81.1M-37.8% | ||
| $432.5M— | —— | —— | —— | —— | ||
| $716.59M+186% | $781.57M+153% | $903.46M+197% | $897.24M+193% | $250.29M-23.6% | ||
| $2.96B+26.6% | $3.03B+25.6% | $2.42B-0.1% | $2.35B-3.0% | $2.34B-5.3% | ||
| 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | 300M0.0% | ||
| -$2.72B-13.6% | -$2.63B-17.0% | -$2.4B-11.9% | -$2.27B-13.4% | -$2.4B-23.6% | ||
| $491.41M+3.3% | $489.09M-16.9% | $617.97M-6.7% | $631.72M+140% | $475.73M+60.4% | ||
| $3.45B+22.6% | $3.52B+17.3% | $3.03B-1.6% | $2.99B+10.9% | $2.81B+1.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ionis Pharmaceuticals's total assets?
- Ionis Pharmaceuticals (IONS) holds $3.4B in total assets, up 22.7% year over year.
- How much debt does Ionis Pharmaceuticals have?
- Ionis Pharmaceuticals carries $691.7M in total debt against $491.4M of shareholders' equity, a debt-to-equity ratio of 1.41.
- How much cash does Ionis Pharmaceuticals have?
- Ionis Pharmaceuticals holds $173.4M in cash and equivalents.
- Can Ionis Pharmaceuticals cover its short-term obligations?
- Its current ratio is 4.10 — current assets exceed current liabilities.
- Where does Ionis Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Ionis Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
